CSDX Share Price Performance
US$0.076
-0.49 (-86.73%)
Price US$0.076
Share PriceUS$0.076
CSDX Community Narratives
There are no narratives available yet.
Recent CSDX News & Updates
No updates
CS Diagnostics Corp. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.00018
- Gross Margin
- 100.00%
- Net Profit Margin
- 18.95%
- Debt/Equity Ratio
- 0%
CS Diagnostics Corp. Competitors
About CSDX
- Founded
- 1996
- Employees
- n/a
- CEO
- WebsiteView website
CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant product; and CS-Protect Hydrogel, a tissue spacer gel for use in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Neuss, Germany.
German Market Performance
- 7 Days: 1.2%
- 3 Months: -2.8%
- 1 Year: 23.7%
- Year to Date: 6.0%
The market is up 1.2% over the last week, with the Communication Services sector leading the way, up 13%. Meanwhile, the Consumer Discretionary sector has underperformed, shrinking 4.7% in that time. As for the past 12 months, the market is up 24%. As for the next few years, earnings are expected to grow by 17% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading